切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2016, Vol. 11 ›› Issue (02) : 107 -112. doi: 10.3877/cma.j.issn.1673-9450.2016.02.006

所属专题: 文献

论著

负压伤口治疗对糖尿病足创面肉芽组织血小板源生长因子表达的影响
杨少玲1, 孙蕾蕾2, 胡丽叶1, 李晓玲1, 杨轶文1, 李艳俊1, 朱旅云1,()   
  1. 1. 050082 石家庄,解放军白求恩国际和平医院内分泌科
    2. 050017 石家庄,河北医科大学研究生学院
  • 收稿日期:2015-11-08 出版日期:2016-04-01
  • 通信作者: 朱旅云
  • 基金资助:
    河北省科技支撑计划项目(12277725); 河北省自然科学基金项目(H2013505067)

Effect of negative pressure wound therapy on the expression of platelet derived growth factor in granulation tissue of diabetic foot wounds

Shaoling Yang1, Leilei Sun2, Liye Hu1, Xiaoling Li1, Yiwen Yang1, Yanjun Li1, Lyuyun Zhu1,()   

  1. 1. Department of Endocrinology, Bethune International Peace Hospital of People′s Liberation Army, Shijiazhuang 050082, China
    2. Graduate School of Hebei Medical University, Shijiazhuang 050017, China
  • Received:2015-11-08 Published:2016-04-01
  • Corresponding author: Lyuyun Zhu
  • About author:
    Corresponding author: Zhu Lyuyun, Email:
引用本文:

杨少玲, 孙蕾蕾, 胡丽叶, 李晓玲, 杨轶文, 李艳俊, 朱旅云. 负压伤口治疗对糖尿病足创面肉芽组织血小板源生长因子表达的影响[J/OL]. 中华损伤与修复杂志(电子版), 2016, 11(02): 107-112.

Shaoling Yang, Leilei Sun, Liye Hu, Xiaoling Li, Yiwen Yang, Yanjun Li, Lyuyun Zhu. Effect of negative pressure wound therapy on the expression of platelet derived growth factor in granulation tissue of diabetic foot wounds[J/OL]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2016, 11(02): 107-112.

目的

探讨负压伤口治疗技术(NPWT)的应用对糖尿病足肉芽组织血小板源生长因子(PDGF)表达的影响。

方法

选取解放军白求恩国际和平医院2010年1月至2014年12月收治的40例糖尿病足患者,采用单纯随机抽样法将患者随机分为NPWT组(20例)和对照组(20例),NPWT组创面采用负压伤口治疗技术治疗,对照组采用传统纱布换药治疗。两组分别于治疗前及治疗第12天取创面肉芽组织2份,一份置于4%多聚甲醛溶液中保存,行苏木精-伊红(HE)染色和免疫组织化学染色,HE染色观察肉芽组织形成情况,免疫组织化学染色观察肉芽组织PDGF的表达情况,通过Motic Medical 6.0数码医学图像分析系统检测吸光度值对PDGF蛋白行定量分析。同时,另一份肉芽组织标本-80℃冰箱中保存,采用Western blot法检测PDGF蛋白表达量。数据应用SPSS 13.0软件进行分析,PDGF吸光度值及PDGF蛋白表达量比较采用两独立样本t检验。

结果

两组治疗前HE染色可见炎症细胞多,成纤维细胞、新生血管形成较少;两组治疗第12天肉芽组织HE染色均可见新鲜肉芽组织的形成,表现为新生血管、成纤维细胞增多,但与对照组相比,NPWT组新生肉芽组织增多较为明显。免疫组织化学分析显示,两组治疗后均可见PDGF蛋白表达上调;NPWT组治疗第12天PDGF吸光度值(0.41±0.05)与治疗前(0.29±0.04)比较,差异有统计学意义(t=8.63,P<0.05);对照组治疗第12天PDGF吸光度值(0.33±0.04)与治疗前(0.28±0.04)比较,差异也有统计学意义(t=3.62,P<0.05);但是,NPWT组治疗前后PDGF吸光度变化值为0.13±0.05,与对照组治疗前后PDGF吸光度变化值(0.05±0.03)比较,差异有统计学意义(t=5.89,P<0.05)。Western blot分析显示,NPWT组治疗第12天PDGF蛋白表达量为0.24 ±0.04,与治疗前PDGF蛋白表达量(0.11±0.03)比较,差异有统计学意义(t=11.01,P<0.05);对照组治疗第12天PDGF蛋白表达量为0.17±0.03,与治疗前PDGF蛋白表达量(0.12 ±0.03)比较,差异亦有统计学意义(t=6.06,P<0.05);但是,NPWT组治疗前后PDGF蛋白表达量的变化值为0.12 ±0.03,与对照组治疗前后PDGF蛋白表达量的变化值(0.05 ±0.02)比较,差异有统计学意义(t=9.06,P<0.05)。

结论

应用NPWT可明显促进创面肉芽组织PDGF表达上调,从而促进创面的愈合。

Objective

To assess the endogenous regulation of platelet derived growth factor (PDGF) in the foot wound healing response induced by negative pressure wound therapy (NPWT) in human diabetic patients in vivo.

Methods

From January 2010 to December 2014, 40 patients with diabetic foot wounds fitting the inclusion criteria were found and enrolled in the clinical trial. The subjects were randomly assigned for NPWT group or control group with simple random sampling method. Twenty patients were treated with NPWT, while the same number of patients in the control group received conventional gauze therapy. Granulated tissue biopsies were collected before(0 day) and after(12 days) treatment in both groups. All biopsies were subdivided into two parts. One part was preserved in 4% paraformaldehyde for hematoxylin eosin staining and immunocytochemical staining of PDGF, the other part was stored at -80℃ for Western blot analysis of PDGF expression. Experimental data were analyzed using SPSS 13.0 software and differences of absorbance value and protein expression of PDGF between the two groups were analyzed using two-sample t test.

Results

The HE staining showed that both NPWT group and control group wounds developed characteristic granulated tissue after treatment, which presented intense fibroblasts and neoformation of vessels. However, NPWT group wounds developed much more characteristic granulated tissue than control group wounds. The immunohistochemical data revealed that PDGF expression was up-regulated in NPWT group and control group after treatment. The absorbance value of PDGF was higher after treatment than that before treatment in NPWT group, the difference was statistically significant (0.41±0.05 vs 0.29±0.04, t=8.63, P<0.05). Also, the absorbance value of PDGF was higher after treatment than that before treatment in control group, the difference was statistically significant (0.33±0.04 vs 0.28±0.04, t=3.62, P<0.05). However, the change value (difference between before treatment and after treatment) of absorbance value of PDGF was higher in NPWT group than that in control group, the difference was statistically significant (0.13±0.05 vs 0.05±0.03, t=5.89, P<0.05). The Western blot analysis of PDGF was consistent with that of immunohistochemical analysis. The protein levels of PDGF was higher after treatment than that before treatment in NPWT group, the difference was statistically significant (0.24 ±0.04 vs 0.11±0.03, t=11.01, P<0.05). Also, the protein level of PDGF was higher after treatment than that before treatment in control group, the difference was statistically significant (0.17±0.03 vs 0.12±0.03, t=6.06, P<0.05). But, the change value ( difference between before treatment and after treatment) of protein level of PDGF was higher in NPWT group than that in control group, the difference was statistically significant (0.12 ±0.03 vs 0.05 ±0.02, t=9.06, P<0.05).

Conclusion

NPWT obviously enhances PDGF expression of granulation tissue in diabetic foot wound and subsequently promotes wound healing.

表1 糖尿病患者人口统计学数据和实验前各观察指标(n=20)
图1 NPWT组与对照组患者治疗前和治疗第12天伤口肉芽组织染色结果分析(苏木精-伊红染色×400)
图2 NPWT组与对照组治疗前和治疗第12天糖尿病足创面肉芽组织PDGF蛋白表达情况(免疫组织化学染色×400)
图3 NPWT组与对照组糖尿病足创面肉芽组织血小板源生长因子吸光度值检测结果
图4 Western blot法检测NPWT组和对照组治疗前和治疗第12天糖尿病足创面肉芽组织PDGF蛋白表达情况
[1]
Wrobel JS, Mayfield JA, Reiber GE. Geographic variation of lower- extremity major amputation in individuals with and without diabetes in the Medicare population[J]. Diabetes Care, 2001, 24(5): 860-864.
[2]
Alavi A, Sibbald RG, Mayer D, et al. Diabetic foot ulcers: Part I. Pathophysiology and prevention[J]. J Am Acad Dermatol, 2014, 70(1): 1.e1-18; quiz 19- 20.
[3]
Lepantalo M, Apelqvist J, Setacci C, et al. Chapter V: Diabetic foot[J]. Eur J Vasc Endovasc Surg, 2011, 42 Suppl 2: S60-74.
[4]
Apelqvist JA, Lepantalo MJ. The ulcerated leg: when to revascularize[J]. Diabetes Metab Res Rev, 2012, 28 Suppl 1: 30-35.
[5]
Canadian Agency for Drugs and Technologies in Health. Negative Pressure Wound Therapy for Managing Diabetic Foot Ulcers: A Review of the Clinical Effectiveness, Cost- effectiveness, and Guidelines [Internet][R]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2014.
[6]
陈波,贲道锋,夏照帆. 负压创面治疗技术的研究应用进展[J/CD]. 中华损伤与修复杂志:电子版,2014, 9(2): 198-202.
[7]
Wackenfors A, Sjogren J, Gustafsson R, et al. Effects of vacuum- assisted closure therapy on inguinal wound edge microvascular blood flow[J]. Wound Repair Regen, 2004, 12(6): 600-606.
[8]
Orgill DP, Bayer LR. Update on negative- pressure wound therapy[J]. Plast Reconstr Surg, 2011, 127 Suppl 1: 105S-115S.
[9]
Schintler MV. Negative pressure therapy: theory and practice[J]. Diabetes Metab Res Rev, 2012, 28 Suppl 1: 72-77.
[10]
Yang SL, Han R, Liu Y, et al. Negative pressure wound therapy is associated with up- regulation of bFGF and ERK1/2 in human diabetic foot wounds[J]. Wound Repair Regen, 2014, 22(4): 548-754.
[11]
Rawlins JM, Lam WL, Karoo RO, et al. Quantifying collagen type in mature burn scars: a novel approach using histology and digital image analysis[J]. J Burn Care Res, 2006, 27(1): 60-65.
[12]
Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing[J]. Front Biosci, 2004, 9(71): 283-289.
[13]
Broughton G 2nd, Janis JE, Attinger CE. The basic science of wound healing[J]. Plast Reconstr Surg, 2006, 117(7 Suppl): 12S-34S.
[14]
Reinke JM, Sorg H. Wound repair and regeneration[J]. Eur Surg Res, 2012, 49(1): 35-43.
[15]
Janis JE, Harrison B. Wound healing: part I. Basic science[J]. Plast Reconstr Surg, 2014, 133(2): 199e-207e.
[16]
Jeffcoate WJ, Price P, Harding KG. Wound healing and treatments for people with diabetic foot ulcers[J]. Diabetes Metab Res Rev, 2004, 20 Suppl 1: S78-89.
[17]
Falanga V. Wound healing and its impairment in the diabetic foot[J]. Lancet, 2005, 366(9498): 1736-1743.
[18]
Braakenburg A, Obdeijn MC, Feitz R, et al. The clinical efficacy and cost effectiveness of the vacuum- assisted closure technique in the management of acute and chronic wounds: a randomized controlled trial[J]. Plast Reconstr Surg, 2006, 118(2): 390-397; discussion 398- 400.
[19]
Vuerstaek JD, Vainas T, Wuite J, et al. State- of- the- art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum- assisted closure (V.A.C.) with modern wound dressings[J]. J Vasc Surg, 2006, 44(5):1029-1037; discussion 1038.
[20]
Xie X, McGregor M, Dendukuri N. The clinical effectiveness of negative pressure wound therapy: a systematic review[J]. J Wound Care, 2010, 19(11): 490-495.
[21]
Werner S, Grose R. Regulation of wound healing by growth factors and cytokines[J]. Physiol Rev, 2003, 83(3): 835-870.
[22]
张明玮,刘志国. 负压创面疗法治疗原理与研究进展[J/CD]. 中华损伤与修复杂志:电子版,2011, 6(6): 1001-1006.
[23]
Efron PA, Moldawer LL. Cytokines and wound healing: the role of cytokine and anticytokine therapy in the repair response[J]. J Burn Care Rehabil, 2004, 25(2): 149-160.
[24]
Barrientos S, Brem H, Stojadinovic O, et al. Clinical application of growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2014, 22(5): 569-578.
[25]
Cooper DM, Yu EZ, Hennessey P, et al. Determination of endogenous cytokines in chronic wounds[J]. Ann Surg, 1994, 219(6): 688-691; discussion 691- 692.
[26]
Cowin AJ, Hatzirodos N, Holding CA, et al. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers[J]. J Invest Dermatol, 2001, 117(5): 1282-1289.
[27]
McNulty AK, Schmidt M, Feeley T, et al. Effects of negative pressure wound therapy on cellular energetics in fibroblasts grown in a provisional wound (fibrin) matrix[J]. Wound Repair Regen, 2009, 17(2): 192-199.
[1] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[2] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[3] 别瑶, 曹志斌, 辛静, 王健楠, 惠宗光. 应用基质血管成分细胞治疗糖尿病足溃疡的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 453-456.
[4] 谢芬, 陈洁, 张媛媛, 刘茜, 胡芬, 李恭驰, 李炳辉, 金环. 移动健康管理模式在糖尿病足管理中的应用效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 335-340.
[5] 苏永涛, 王春雷, 徐广琪, 关中正, 焦伟, 隋颖. 胫骨骨膜牵张术联合富血小板血浆对治疗糖尿病足溃疡的疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 238-244.
[6] 杨丽, 李文颖, 田园, 周林熙, 王伟. 脂质水胶体硫酸银敷料和蔗糖八硫酸盐敷料在糖尿病足溃疡中的应用进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 271-275.
[7] 廖晓霜, 曾李, 杨波. 脱细胞同种异体真皮联合自体皮修复糖尿病足创面的临床效果[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(01): 46-50.
[8] 孙艺玮, 陈炜, 秦巍, 杜景辰, 孟昕, 周永军. 血管腔内介入治疗糖尿病足合并下肢动脉硬化闭塞症患者术后再狭窄与血清炎症因子的相关性[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(01): 34-40.
[9] 张健, 刘小龙, 查天建, 姚俊杰, 王傑. 富含血小板血浆联合异种脱细胞真皮基质修复糖尿病足缺血性创面的临床效果[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(06): 503-506.
[10] 赵雅玫, 谢斌, 陈艳, 吴健. 抗生素骨水泥联合负压封闭引流对糖尿病足溃疡临床疗效的荟萃分析[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(05): 427-433.
[11] 鲍亚慧, 曹志斌, 王健楠, 别瑶, 孙晓东, 惠宗光. 应用羧甲基纤维素钠银敷料联合封闭负压吸引治疗糖尿病足溃疡的疗效[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(04): 326-330.
[12] 雷霞, 李炳辉, 王晓蓉, 张丽娟, 刘慧真, 王卉, 李恭驰. 对糖尿病足溃疡诱因与发生部位的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(02): 104-108.
[13] 翟延荣, 朱亚萍, 张秀珍, 钟晓娟, 鲁香月, 张雨凡, 陆树良. 比较新型硅橡胶负压冲洗引流系统与聚氨酯负压引流系统体外防堵塞性能的观察[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(02): 116-122.
[14] 余静雅, 戴燕, 石玉兰, 向利娟, 吴淑君. 对门诊糖尿病足患者治疗费用的分析[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(02): 128-133.
[15] 黄晨, 庄炜钊, 刘合祝, 李永生, 王倩, 唐郁宽. 富血小板凝胶联合腔内血管成形术治疗缺血性糖尿病足的研究[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 27-32.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?